Apolipoprotein C-III; Human Plasma; Very Low-Density Lipoprotein

Not available outside of the UK & Ireland.

General description

Native apolipoprotein C-III from human plasma. Present in normal plasma at 80-150 µg/ml. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II.

Native apolipoprotein C-III from human plasma. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II. Present in normal plasma at 80-150 µg/ml.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Bonnet, E., et al. 2001. J. Clin. Endocrinol. Metab.86, 296.Hasse, R., et al. 1998. Electrophoresis 9, 569.Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.

Packaging

100 µg in Plastic ampoule

Please refer to vial label for lot-specific concentration.

Physical form

In 10 mM NH₄HCO₃, pH 7.4.

Preparation Note

Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Reconstitution

Following initial thaw, aliquot and freeze (-20°C).

Warning

Toxicity: Standard Handling (A)